Pfizer (PFE) Lacks Earnings Momentum According to Analyst Jim Cramer
Published on 5/14/2026

AI Summary
Analyst Jim Cramer stated that Pfizer (PFE) does not have any current earnings momentum. This observation could indicate potential concerns regarding PFE’s future stock performance in the market. Without positive earnings momentum, investor confidence may decline, potentially affecting the stock's valuation. It is essential for investors to monitor PFE's earnings reports closely to gauge any changes in momentum.
Related News

Earnings
GameStop (GME) Reports $7.4 Billion Cash Amid Transformation Efforts
Jun 28

Earnings
Meta (META) Reports 33% Revenue Growth; Snap (SNAP) Hits $1.5B
Jun 28

Earnings
Starwood Property Trust (STWD) Offers 11.5% Dividend Yield Now
Jun 28

Earnings
SPHD and DIVO ETFs Offer Reliable Monthly Income for Retirees
Jun 28